Cnoga TensorTip Combo
The technology used in the Cnoga TensorTip Combo, to measure blood glucose, has been assessed, in a general population, according to a non-standard protocol.
|Medaval||None||When an evaluation is carried out using a non-standard protocol, no inference can be made on accuracy based on a standard protocol.|
Pfützner A, Strobl S, Demircik F, Redert L, Pfützner J, Pfützner AH, Lier A. Evaluation of a New Noninvasive Glucose Monitoring Device by Means of Standardized Meal Experiments. J Diabetes Sci Technol. 2018 Nov;12(6):1178-1183. Epub: 2018 Feb 16. doi: 101177/1932296818758769. PMID: 29451016. Available from: PMC6232728.
Ad Hoc protocol Healthy (n=14), T1DM (n=6) and T2DM (n=16)
After appropriate individual calibration of the noninvasive technology, both the noninvasive and the invasive Cnoga TensorTip-Combo components tracked tissue and blood glucose values reliably, respectively. This may enable patients with diabetes to monitor their glucose levels frequently, reliably and, most of all, pain-free.
Segman YJ. Device and Method for Noninvasive Glucose Assessment. J Diabetes Sci Technol. 2018 Nov;12(6):1159-1168. Epub: 2018 Mar 24. doi: 10.1177/1932296818763457. PMID: 29575926. Available from: PMC6232732.
Measurements from the Cnoga TensorTip Combo are compared to those from Roche Accu-Chek Performa, Ascensia Contour, Abbott FreeStyle and Abbott i-STAT, though not in a formal validation.